On this page:OverviewFunded papers
ScholarIQanswers from OpenAlex

Innovent Biologics

FunderResearch funding and supported work

Innovent Biologics is a funder indexed in ScholarIQ from OpenAlex.

What is known about Innovent Biologics?

ScholarIQrecord summary

Pharmaceutical company in China

How many works does Innovent Biologics have?

ScholarIQindexed works

Innovent Biologics has 466 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

What is the OpenAlex record for Innovent Biologics?

ScholarIQopenalex

The OpenAlex for Innovent Biologics is on the source record.

What are the most-cited papers on Innovent Biologics?

ScholarIQmost cited works
Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups
Kenneth W. Mahaffey, Meg Jardine, Séverine Bompoint, Christopher P. Cannon, Bruce Neal, Hiddo J.L. Heerspink, David M. Charytan, Robert Edwards, Rajiv Agarwal, George L. Bakris, Scott Bull, George Capuano, Dick de Zeeuw, Tom Greene, Adeera Levin, Carol A. Pollock, Tao Sun, David C. Wheeler, Yshai Yavin, Hong Zhang, Bernard Zinman, Norman Rosenthal, Barry M. Brenner, Vlado Perkovic, On behalf of the CREDENCE Study Investigators
Circulation. 2019291 CitationsOPEN ACCESS
470M+ articles · 14-day free trial